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Abstract
Background: Proteins destined to be Glycosylphosphatidylinositol (GPI) anchored are translocated into the ER lumen
completely before the C-terminal GPI anchor attachment signal sequence (SS) is removed by the GPI-transamidase and
replaced by a pre-formed GPI anchor precursor. Does the SS have a role in dictating the conformation and function of the
protein as well?
Methodology/Principal Findings: We generated two variants of the Als5 protein without and with the SS in order to
address the above question. Using a combination of biochemical and biophysical techniques, we show that in the case of
Als5, an adhesin of C. albicans, the C-terminal deletion of 20 amino acids (SS) results in a significant alteration in
conformation and function of the mature protein.
Conclusions/Significance: We propose that the locking of the conformation of the precursor protein in an alternate
conformation from that of the mature protein is one probable strategy employed by the cell to control the behaviour and
function of proteins intended to be GPI anchored during their transit through the ER.
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Introduction
A wide variety of proteins are known to be anchored to the
extra-cytoplasmic leaflet of the plasma membrane by glycosylpho-
sphatidylinositol (GPI) anchors and defects in GPI anchor
attachment can have severe consequences for the eukaryotic cell
[1]. Proteins destined to be GPI anchored possess a C-terminal
signal sequence specific for this modification [2]. Unlike integral
membrane proteins that have their transmembrane domains co-
translationally inserted into the membrane via the translocon pore,
proteins meant to be GPI anchored are completely translocated
into the ER lumen [3]. Shortly thereafter, these are acted upon by
the GPI-transamidase and have their C-terminal GPI anchor
attachment signal sequence (SS) replaced by a pre-formed GPI
anchor.
Is the role of the SS confined to being a signal for GPI anchor
attachment or does it also control the conformation and function
of a protein destined to be GPI anchored? In order to address this
question, we chose to study Als5, an adhesin from Candida albicans.
ALS5 belongs to the agglutinin-like sequence (ALS) family of
genes which code for eight adhesins in Candida albicans. These
adhesins are important for establishment of commensal colonies of
the organism in the host as well as in its pathogenesis and virulence
under appropriate conditions [4]. Since they are tethered to the
membrane via GPI anchors, any defects in GPI anchor
biosynthesis can drastically affect the pathogenesis and virulence
of the organism [5–7]. Indeed, complete GPI anchors have been
shown to be important for morphogenesis, virulence and
macrophage-resistance of the organism [7].
Like other members of the Als family of adhesins, Als5 has an
N-terminal secretion signal followed by a large immunoglobulin-
like domain, a highly conserved Thr-rich segment, a central
domain containing variable numbers of tandem repeats of Ser/
Thr sequences, a C-terminal Ser/Thr rich stalk and the C-
terminal signal sequence for GPI anchor attachment [8]. When
heterologously expressed in S. cerevisiae, Als5 can make the host
cells adhere to basal lamina proteins such as collagen type IV and
fibronectin [9]. The protein has also been shown to be capable of
mediating endothelial cell invasion and its N-terminal domain has
been shown to be important for adherence [10,11]. The protein
has a tendency to aggregate and form amyloid-like fibrils; a
potential amyloidogenic domain has also been identified [11–13].
In this study, we show that it is possible to express Als5 as a
GST-fusion protein in bacterial cells and to purify it using affinity
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capable of adhering to collagen and forming self-aggregates, and is
therefore ‘functional’. In contrast, we show that the Als5-SS
variant, possessing the GPI achor attachment signal sequence,
poorly binds to collagen type IV and does not form aggregates. We
attribute this to the differences in the secondary structure of the
two proteins. The implications of these results are discussed in the
context of the cell.
Materials and Methods
Materials
All chemicals were of analytical grade and were purchased
either from Qualigens, Merck, SRL or Sigma-Aldrich (USA).
Components of media were purchased from Himedia (India);
DH5a and BL21(DE3) cells as well as glutathione-agarose beads
from Bangalore Genei; PreScission
TM protease and pGEX-6P-
2 from GE-Healthcare; restriction enzymes as well as DNA and
protein molecular weight markers from MBI Fermentas; collagen
type IV from Sigma; gel extraction kit from Qualigens; anti-GST
antibodies were from Santa Cruz, protease cocktail inhibitor
(P8340) from Sigma; N-gycosidase F from Roche. Peptide
synthesis was carried out by Custom Peptide Synthesis service of
USV Ltd. (India). The primers (Table S1) were custom-
synthesized by Sigma-Aldrich.
Cloning of ALS5 Gene with and without the C-terminal
GPI Anchor Attachment Signal Sequence for Expression
in E.coli
We began with cloning, expression and purification of Als5
protein from the CAI4 strain (a derivative of SC5314,
ura3D::imm434/ura3D::imm434)o fCandida albicans. This strain has
two different alleles for Als5, varying in the number of sequences
coding for the tandem repeats. The one corresponding to the
smaller allelic variant of ALS5 was used for this study. Full length
ALS5 gene minus the GPI anchor attachment signal sequence
(3985–4044 bp), was amplified from the C. albicans CAI4 strain
using PCR (Table S1), with Pfu polymerase and ligated into the
pGEX-6P-2 vector, containing the GST affinity tag, between the
BamHI and XhoI sites. The ligation product was transformed into
competent DH5a cells and colonies were screened by colony
PCR. Plasmid was extracted from the PCR-positive colonies, and
the clone confirmed by restriction digestion of the plasmid by
BamHI and XhoI enzymes.
DNA sequence analysis confirmed the sequence of the cloned
ALS5 gene as compared to the reported ALS5 sequence in the
Candida genome database (www.candidagenome.org). The pro-
tein expressed from this construct is referred to here as GST-Als5.
Similarly, ALS5-SS, an ALS5 variant, with the GPI-anchor
attachment signal sequence was cloned into the pGEX-6P-2 vector
under the BamHI and XhoI sites. The protein expressed from this
construct is referred to as GST-Als5-SS.
Expression and Purification of GST-Als5 and GST-Als5-SS
Proteins
The expression of the GST-Als5 and the GST-Als5-SS proteins
were optimized with respect to IPTG concentration, induction
period and temperature. Thus, we induced protein expression at
16
oC for 6 hours using 0.1 mM IPTG concentration.
The cell pellets were resuspended in lysis buffer (10 mM
PMSF, 150 mM NaCl, 50 mM sodium phosphate buffer
(pH 8.0), 5% glycerol, 0.1 mg/ml lysozyme, 1:100 diluted
protease inhibitor cocktail), incubated at 4uC for 1 hour, then
sonicated (7 cycles, 30s ON, 30s OFF). The cell lysate obtained
was centrifuged at 8500 rpm for 1 hour to recover the
supernatant, which was loaded onto pre-equilibrated glutathi-
one-agarose beads and incubated for 3 hours at 4uCo nar o c k e r .
This was followed by extensive washing of the beads with wash
buffer [50 mM sodium phosphate buffer (pH 8.0), 3 M NaCl].
The protein was then eluted with elution buffer (50 mM sodium
phosphate buffer (pH 8.0), 150 mM NaCl, 20% glycerol,
10 mM glutathione).
Western Blots
The purified fractions of GST-Als5 and GST-Als5-SS were
confirmed by Western blotting, using polyclonal anti-GST
antibody or anti-Als5 antibody as the primary antibody for
detection of the GST-tagged proteins. The binding of primary
antibody was detected by the HRP-conjugated secondary
antibody. The presence of secondary antibody on the blot was
detected by using diaminobenzidine as a substrate for HRP.
Anti-Als5antibodies
The production of the antibodies was outsourced (Merck India
Ltd.). Polyclonal antibodies were generated in rabbit against the
protein band obtained after an SDS-PAGE run of GST- Als5-
SS. The antibodies detected both GST-Als5 as well as GST-
Als5-SS on a Western Blot. The specificity of the generated anti-
Als5 antibody was checked by detecting its ability to bind to the
Candida cell surface adhesins. For staining, Candida SC5314
cells (a kind gift from Prof. Rajendra Prasad, SLS, JNU) were
grown in synthetic dextrose minimal medium at 30uCt oa n
OD600nm of 0.5. 500 ml of the cells were taken in an eppendorf
and washed with PBS. The cells were then incubated with anti-
Als5 primary antibody (diluted1:1,000 in 1% skimmed milk in
PBS, 0.05% Tween-20) for 1 hour at room temperature. The
cells were then washed thrice with PBS and incubated for 1 hour
with TRITC labelled anti-rabbit secondary antibody (diluted
1:5000 times in 1% skimmed milk in PBS, 0.05% Tween-20) for
1 hour at room temperature. The cells were then washed thrice
with PBS, and the presence of the TRITC labelled secondary Ab
on the Candida cells was detected using flow cytometry. To rule
out the non-specific interaction of the secondary Ab with the
proteins on Candida cell surface, unstained cells were also
detected by flow cytometer. In the unstained set, the cells were
incubated with the buffer alone used for the primary antibody
instead of the anti-Als5 primary Ab, and were processed
otherwise similarly to the stained set (mentioned above). Further,
the specificity of the primary antibody to bind to Candida cell
surface Als5 was checked by the ability of the purified GST-Als5
to inhibit the binding of the anti-Als5 Ab on the Candida cell
surface. For this, the cells were incubated with purified GST-
Als5 prior to the incubation with anti-Als5 Ab, and were
processed otherwise similarly to the stained set. As a control,
experiment with GST was also similarly performed. Different
concentrations of both the proteins were used to establish the
specificity of the anti-Als5 Ab interaction with the Candida cell
surface Als5.
Mass Spectrometric Analysis
The purified GST-Als5 and GST-Als5-SS proteins were
analysed for intact mass by MALDI-TOF (Bruker). Further, for
confirmation of the identity of the proteins, in-gel tryptic digestion
was carried out and the peptide fragments analysed by MALDI-
TOF.
Als5 from C. albicans
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(CD) Spectra
The secondary structure analysis of freshly purified GST-Als5
and GST-Als5-SS proteins was done by CD spectroscopy. The
concentrations of the proteins were determined using Bradford
reagent. The proteins were then dialysed against 50 mM
potassium phosphate buffer (pH 8.0), containing 150 mM KCl
and 20% glycerol. After dialysis and centrifugation, the concen-
trations of the proteins were adjusted to 0.09 mg/ml and the CD
spectra of the proteins were recorded at 25uC on a Chirascan
(Applied Photophysics) CD spectrometer between 190–260 nm at
medium scan speed, with 1 nm step length, in a cuvette of 1 mm
path length. The final spectrum was an average of three repeat
scans. Background corrections for buffer were done. The spectra
for Als5 and Als5-SS were obtained by subtracting the spectrum of
GST protein from the respective spectrum of GST-Als5 and GST-
Als5-SS using the Pro-Data software that comes along with the
instrument. The resultant spectra were further analysed using
CONTIN [14].
Adhesion Assay
Freshly purified GST-Als5 and GST-Als5-SS were checked for
their ability to bind to human collagen type IV, following a slightly
modified method to that reported [8]. Briefly, a 96-well flat bottom
plate was coated with different amounts of collagen type IV and
incubated overnight at 4uC. The plate was then washed thrice with
PBS and twice with elution buffer. 200 ml of 0.09 mg/ml of either
GST-Als5-SS, GST-Als5 or GST (control) was added to each well
and incubated at 37uC for 1 hour. The wells were blocked for
1 hour with 5% skimmed milk in PBS and then washed 5 times
with wash buffer (1% skimmed milk, 0.025% Tween-20 in PBS).
Thereafter, 200 ml/well of primary anti-GST antibody (diluted
1:1,000) was added. After incubation at 37uC for 1 hour, the wells
were washed five times with wash buffer and incubated at 37uC
with HRP-conjugated secondary antibody (200 ml/well; diluted
1:20,000) for 1 hour. The wells were rinsed five times with wash
buffer, 100 ml of freshly prepared tetramethylbenzidine solution
was added to each well and incubated at 37uC for 1 hour.
OD650nm was monitored on a plate reader (Spectramax M2).
Appropriate controls (without immobilised collagen, without GST-
Als5/GST-Als5-SS proteins, and without primary antibody) were
also done. ‘‘Buffer control’’ refers to the control with no collagen
immobilized.
Transmission Electron Microscopy (TEM)
TEM studies were carried out on a JEOL 2100F. The proteins
(0.09 mg/ml) were incubated at 37
oC for 2 weeks prior to the
measurements. The proteins were spotted on a carbon-coated
copper grid and positively stained with 2% uranyl acetate. The
sample was then dried and examined by TEM using a 210 kV
accelerating voltage.
Peptide Binding Studies
Binding of GST-Als5 and GST-Als5-SS proteins to different
peptides was monitored by fluorescence emission spectroscopy.
Freshly purified samples of protein were used each time. 0.02 mg/
ml of the proteins were taken and the tryptophan-specific emission
spectra were monitored between 310 nm to 400 nm by excitation
at 295 nm. The peptides were titrated into the protein solutions,
incubated for 5 minutes after each addition, and emission spectra
recorded. Both excitation and emission bandwidths were fixed at
5 nm and all spectra were averages of 5 scans. All spectra were
corrected for buffer and peptide backgrounds. Purified GST alone
at the same concentrations did not yield any significant
fluorescence emission spectrum.
All binding data were analyzed using a one-site saturation
model. Binding studies were done at different temperatures, and
DG
o for the protein-peptide interactions calculated using the
equation: DG
o=– RTlnKa. DH
o and DS
o were obtained from the
slope and intercept of the van’t Hoff plots according to the
equation: lnKa~{
DH0
RT
z
DS0
R
:
Modelling and Docking Studies
The three dimensional structure of Als5 N-terminal domain
(Als5Nt), Als5Nt in complex with portion of the C-terminal SS
peptide (residues 1337–1347), Als5Nt with both the SS peptide
and a peptide ligand (EHAHTPR) were modelled using the
Rosetta 3.2 biomolecular comparative modelling and docking
suite [15].
Model of Als5Nt. The structure of N-Terminal domain of
the C. albicans Als9–2-apo form (PDB ID 2Y7N) was used for the
construction of Als5Nt. The modelled protein shared 66% identity
and 78% similarity with Als9–2.
Model of Als5Nt-SS peptide and Als5Nt-SS peptide in
complex with peptide ligand. The structure of Als5Nt bound
with a portion of the flexible SS peptide was obtained using
Rosetta FlexPepDock module [16]. The starting complex structure
was built on the basis of coarse-grained structural representation of
the signal peptide and the receptor, as seen in the bG29 strand in
N-terminal domain of C. albicans Als9–2 in complex with human
fibrinogen c peptide (PDB ID 2Y7L). The last 11 amino acid
residues (KFISVALFFFL) from the C-terminal signal sequence
peptide of Als5-SS were modelled using 2Y7L C-terminal end
which forms an extended strand (bG29) over domain N1 in the
Als9–2 structure [17]. Based on the docking simulation results
1000 models were generated. The ensembles were sorted by
Rosetta scoring function, out of which the best model was selected
for representation.
The model of Als5Nt-C-terminal signal peptide in complex with
peptide ligand was then obtained using 2Y7L as template. The
peptide ligand (EHAHTPR) was modelled using Fg-c peptide as
template.
All the structures were further minimized to eliminate bad
atomic contacts. The molecular minimization simulations were
done with the help of AMBER [18] molecular dynamics package
using amber force field and steepest descent algorithm to remove
close van der Waals contacts, followed by conjugate gradient
minimization until the energy was stable in sequential repetitions.
All hydrogen atoms were included in the calculation.
Results
In order to address the issue of whether the SS is merely a signal
for GPI anchor attachment in Als5 or whether it also has a say in
the conformation and function of the protein, we generated the full
length Als5 as well as its variant carrying the GPI-anchor signal
sequence (Als5-SS) as GST-fusion products (Figure 1A) and did a
comparative study of their conformation and function. The results
are presented below.
Cloning, Expression and Purification of GST-Als5 and
GST-Als5-SS
The N-terminally GST-tagged protein variants, without the
signal sequence (Als5) and with the GPI anchor attachment signal
sequence (Als5-SS) were generated and confirmed as described in
Methods (Figure S1). The proteins were expressed in E. coli BL21
Als5 from C. albicans
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proteins so that the GST-Als5-SS protein would be obtained with
the SS peptide intact. A eukaryotic host would have resulted in
processing of the GST-Als5-SS, and would not have allowed us to
address the role of the SS sequence in the conformation/function
of Als5.
The molecular weight of the GST tag is ,26 kDa. Hence, for
the GST-Als5 and the GST-Als5-SS proteins the molecular
weights were expected to be around 166 kDa and 168 kDa,
respectively. However, we observed bands of Mr ,270 kDa, for
both GST-Als5 and GST-Als5-SS (Figure 1B). This marked
difference between the observed molecular weights in SDS-PAGE
and the expected molecular weights has been previously attributed
to the high content of hydroxyl amino acids in proteins [11]; both
Als5 and Als5-SS are rich in serine and threonine residues. The
concentrations of the proteins are low, as can be seen from the
gels. Attempts to concentrate the proteins any further, however,
resulted in most of the GST-Als5 protein aggregating and
precipitating out.
Along with the ,270 kDa main band, a much fainter lower
band is also present in both gels despite the use of protease
inhibitor cocktail in the lysis buffers which is not so obvious when
viewed by Coomassie Brilliant Blue R250 staining (panels (i) & (ii)
of Figure 1B) but shows-up as a faint band on Western Blots using
anti-GST (Figure 1C, panel (i)) as well as anti-Als5 antibodies
(Figure 1C, panel (ii)). The levels of the degradation products were
roughly similar in the two cases. That these were GST-tagged
proteins and probably represent degradations of the main proteins
of interest was obvious from the Western Blots. From the
intensities of the bands, we assessed that the levels of purity of
the two proteins were . 90% in the elution samples and thus the
levels of the degradation products were not likely to significantly
alter the results of our experiments.
The identities of the two proteins were confirmed by peptide
mass fingerprint using MALDI-TOF analysis as well as ESI-MS.
The data obtained for GST-Als5-SS using MALDI-TOF, ESI-MS
and intact mass analysis (168.6 kDa) is given in Figures S2, S3 and
S4, respectively.
It must be pointed out that a PreScission
TM protease site exists
between the fusion tag and the Als5 proteins in the two constructs.
However, our attempts to cleave off the fusion tag with the
protease met with poor success. The PreScission
TM protease is also
available as a GST-tagged enzyme and it is possible that steric
factors precluded the interaction of the protease with the cleavage
site in our fusion protein. Additionally, our protein yields to begin
with were very low (,0.09 mg/ml) and this too could have
affected the efficiency of the cleavage. Concentrating the proteins
was not an option since GST-Als5 tended to aggregate and
precipitate out of solution. Hence all our studies were carried out
with the fusion proteins. We used similarly expressed and purified
GST as the control for all our experiments. Similar studies with
GST-tagged proteins, including conformational studies, have been
reported by other groups previously (cf. [19]).
In order to confirm the identity of the Als5 protein, we also
designed the following experiment. We first used anti-Als5
antibodies to bind to C. albicans SC5314 cell surface. Using a
TRITC labelled secondary antibody, we detected the bound
primary antibodies on the Candida cells by flow cytometry. As can
Figure 1. Preliminary characterization of GST-Als5 and GST-Als5-SS. (A) Cartoon depicting the difference between GST-Als5 and GST-Als5-
SS. GST is fused at the N-terminus of both the proteins. GST-Als5 has only the protein sequence of the Als5 mature protein while GST-Als5-SS has, in
addition to the Als5 mature protein sequence, the GPI-anchor attachment signal sequence (SS) of 20 amino acids also included in the expressed
protein. (B) SDS-PAGE showing purification of GST-Als5 and GST-Als5-SS. The proteins were expressed and purified as described in Experimental
Procedures. The purified elutes were run on a 6% SDS polyacrylamide gel and stained using Coomaassie Brilliant Blue R250. (i) Purification of GST-
Als5. (ii) Purification of GST-Als5-SS. In each gel, Lanes M: Molecular weight markers; 1: elution fraction with 10 mM glutathione. The arrow indicates
the bands of interest. The purified proteins showed a molecular weight much higher (around 270 kDa) than expected (around 168 kDa). The higher
than expected molecular weights for both the proteins can be attributed to high content of serine and threonine residues in both the proteins [8]. (C)
Western Blot confirmations of the purified GST-Als5 and GST-Als5-SS. The purified proteins were run on a 6% SDS polyacrylamide gel and transferred
to PVDF membrane. The membrane was probed using anti-GST and anti-Als5 antibodies as described in Experimental Procedures. (i): Blot using anti-
GST antibody. (ii): Blot using anti-Als5 antibody. Lanes M: Pre-stained protein molecular weight markers; 1: Purified GST-Als5; 2: GST-Als5-SS. The
arrow indicates the bands of interest. Both the antibodies recognized the protein bands of around 270 kDa.
doi:10.1371/journal.pone.0035305.g001
Als5 from C. albicans
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by the antibodies. Next, we attempted to compete out the binding
of the anti-Als5 antibodies to the C. albicans cells using GST-Als5.
To ascertain the specificity of the interaction, we used both GST
as well as GST-Als5 in these competition assays, where the
individual proteins were present in the sample before addition of
the primary antibodies. As can be seen from Figure 2, while GST
could not inhibit the binding of the antibodies on the cell surface,
the GST-Als5 protein could inhibit the interaction of the primary
antibodies to the cell surface in a concentration dependent
manner.
Als5 Binds Collagen Type IV
Several studies have shown that collagen type IV is one the
proteins of the extracellular matrix that is specifically recognized
by C. albicans cells during infection [9]. Homology studies
identified Als5 as a protein homologous to collagen binding
proteins [10]. We performed an adhesion assay that involved
different amounts of immobilised collagen type IV as described in
Methods. We observed interaction of each of the Als5 protein
variants with collagen type IV which depended upon the amount
of collagen used for the immobilization (Figure 3A). More
interestingly, GST-Als5 had greater adherence to collagen type
IV as compared to GST-Als5-SS. In contrast, GST alone showed
very poor interaction with collagen type IV.
In order to see whether the carbohydrate chains on collagen
type IV had any role in Als5 adhesion, we treated the immobilized
collagen type IV in our adhesion assays with 0.5 U of N-
glycosidase F (Roche). We observed a roughly 20% drop in
adhesion of GST-Als5 to collagen type IV after deglycosylation
with the enzyme for 2 hours (Figure 3B; flow chart of methodology
in Figure S5). Increasing the deglycosylation time to 3 hours did
not further reduce the adhesion of GST-Als5 to collagen type IV
(data not shown). Thus, Als5 may use the carbohydrate side chains
of collagen in addition to the peptide backbone of collagen and
other similar proteins for adhesion.
That some adhesins may also use carbohydrate ligands present
on collagen type IV was also suggested by Timoneda’s group [20].
More recently, the N-terminal domain of Als1 was shown to bind
fucose-containing sugars from a glycan array with millimolar
affinity, although the glycan could not significantly and specifically
inhibit the binding of the adhesin to laminin or fibronectin [21].
Secondary Structure of Als5 is Different from that of Als5-
SS
To understand whether this difference in collagen-binding was
due to conformational differences between the two proteins, we
analyzed the structure of the two proteins using CD spectroscopy.
The CD spectra of Als5 and Als5-SS (after subtracting the
spectrum of GST from that of the fusion proteins) are shown in
Figure 4A. The structural differences between the two proteins are
very obvious from the figure.
The Als5 spectrum closely resembled that of intrinsic pre-
molten globules [22]. However, no prediction programs are
currently available that have a database of CD spectra from
intrinsically disordered proteins that would have enabled us to fit
Figure 2. GST-Als5 specifically blocks binding of anti-Als5 antibody on Candida cell surface. Candida SC5314 cells were grown to an
OD600nm of 0.5. 500 ml of the cells after pelleting down were washed with PBS and then incubated with anti-Als5 antibody for 1 hour. This primary
antibody was detected by a secondary antibody that was conjugated with TRITC and detected using flow cytometry as described in the text. The y-
axis in the figure represents the percent fraction of fluorescently labelled cells. Unstained: Cells were incubated with the primary Ab buffer (instead of
anti-Als5 Ab), washed thrice with PBS and then incubated with the fluorescently labelled secondary antibody before being detected using flow
cytometry. Anti-Als5: Cells were incubated with anti-Als5 primary Ab, washed thrice with PBS and then incubated with the fluorescently labelled
secondary antibody before being detected using flow cytometry. GST: Cells were incubated with GST, then with anti-Als5 Ab, washed thrice with PBS,
and then incubated with the fluorescently labelled secondary antibody before being detected using flow cytometry. Als5: Cells were incubated with
GST-Als5, then with anti-Als5 Ab, washed thrice with PBS, and then incubated with the fluorescently labelled secondary antibody before being
detected using flow cytometry. All incubation steps were carried out at 37
oC for 1 hour. Concentrations of the GST as well as GST-Als5 used in the
competition assays are as shown in the figure. The data presented is mean of 3 independent experiments done in duplicates. The anti-Als5 antibody
generated in this study was able to recognize and bind to the adhesins on Candida cell surface, as exhibited by the fraction of fluorescent cells
detected using TRITC labelled secondary Ab. The presence of GST-Als5, but not GST, inhibited the binding of anti-Als5 antibody to C.albicans cell
surface in a concentration dependent manner, thus demonstrating the specificity of the interaction.
doi:10.1371/journal.pone.0035305.g002
Als5 from C. albicans
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determined by it. (A) Adhesion of GST-Als5, GST-Als5-SS to collagen type IV. Different amounts of collagen type IV, as shown in the figure, were
immobilized in 96-well flat bottomed ELISA plates and incubated with the proteins (0.09 mg/ml) of interest at 37
oC for 1 hour. The adhesion assay
was carried out as described in Experimental Procedures. Adhesion of the proteins to collagen type IV was correlated to the absorbance at 650 nm
observed by the oxidation of TMB, the substrate of HRP. Filled square: binding of GST-Als5; open triangle: binding of GST-Als5-SS; star: binding of GST
alone. The binding by GST alone represents the non-specific binding. Buffer controls (OD 650nm of 0.126 6 0.003), corresponding to no immobilized
collagen, have been subtracted in all cases. Signal from the controls (without immobilised collagen, without GST-Als5/GST-Als5-SS/GST proteins, and
without primary antibody) were similar to the buffer control. The data presented is mean of 3 independent experiments done in duplicates. GST-Als5
showed greater adherence to collagen type IV as compared to GST-Als5-SS. GST showed very poor interaction with collagen type IV. (B) Treatment of
collagen type IV with N-Glycosidase F results in decrease in adherence of GST-Als5. Collagen type IV (100 ml; 1 mg/ml) was immobilised overnight at
4
oC in 96-well ELISA plate. The wells were then rinsed 5 times with PBS and incubated with N-glycosidase F (Roche) for 2 hours at 37
oCi n5 0m M
sodium phosphate buffer (pH 8.0) containing 25 mM EDTA and 1% v/v b-mercaptoethanol. After washing 5 times with PBS, GST-Als5 was added and
incubated for an hour. Adherence to collagen type IV was detected as already described. No Glycosidase: Only the buffer of the glycosidase was
added. With glycosidase: 0.5 U glycosidase was added. All other wells were also incubated at 37
oC with buffer of the glycosidase. GST control: GST
was added in place of GST-Als5 to monitor the non-specific interaction; Buffer control: No immobilized collagen; Without primary Ab: The step where
primary Ab was to be added was replaced with incubation with the buffer only. Average values for 3 independent experiments done in duplicates are
shown with standard deviations. p-values representing statistical significance of data with respect to ‘No Glycosidase’ data are shown in figure. Flow
chart representing the various steps of the assay is shown in Figure S5.
doi:10.1371/journal.pone.0035305.g003
Figure 4. Secondary structure of Als5 and Als5-SS are perceptibly different. (A) CD spectra of Als5 and Als5-SS. Individual CD spectra
were recorded for 0.09 mg/ml each of GST-Als5, GST-Als5-SS and GST and the spectrum for GST was subtracted from that of the GST-tagged fusion
proteins in order to obtain the final CD spectra of Als5 (trace 3) and Als5-SS (trace 2). The spectrum of GST alone (1) is also shown in the figure. The
values are reported as mean residue ellipticity (MRE) in degrees-cm
2dmol
-1. The curves were smoothened using the Savitzky-Golay smoothing
function in the Origin software (Microcal). The spectrums of Als5 and Als5-SS are clearly distinct from each other. (B) Prediction of disordered regions
in Als5 using PONDR-Fit. The Als5 protein sequence was fed into the on-line prediction program available at http://www.disprot.org/pondr-fit.php to
predict whether there were any disordered regions in the protein. The grey line at 0.5 of Y-axis is the threshold; residues with score above 0.5 are
predicted to be disordered while those below 0.5 are predicted to be ordered.
doi:10.1371/journal.pone.0035305.g004
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use an on-line prediction program, PONDR-Fit [23], to determine
whether there are intrinsically disordered regions in the Als5
protein. As can be seen in Figure 4B, a large portion of the protein
(,70%), in its C-terminal half, is predicted to be significantly
disordered. There is increasing evidence to suggest that such
intrinsic disorder is very important for the functionality of many
proteins, and disordered regions of many proteins are shown to
attain structure only in the presence of ligand and/or during
‘function’ [22]. Given that the C-terminal domain is capable of
mediating cell-cell adhesion [11], it is possible that the stalk region
of these proteins remains flexible and attainment of structure in
this domain is dependent on cell-to-cell contacts.
When analysed by CONTIN [14], Als5, has a b-strand-rich
structure with a significant amount of b-turns and disordered
regions (the closest matching solution suggested 25.4% b strand,
9.2% a-helix, 43.8% turn and 21.6% disordered regions while the
average of all matching solutions suggested 38.3% b strand, 6.4%
a-helix, 42.6% turn and 12.6% disordered regions) (Table S2).
The structure in the CD signal is, perhaps, largely contributed by
the N-terminal half of the protein which is predicted to be well-
folded by PONDR-Fit.
There is experimental evidence to suggest that the N-terminal
domain of Als5 and other Als-like adhesins may be well folded.
The isolated N-terminal domain of Als5 has been estimated to
contain 50.1% b-sheet, 26.9% disordered regions, 19.3% turns
and only 3.7% a-helix using CD spectroscopy [10]. The NMR
structure of the N-terminal domain of Als1 [24] as well as the
crystal structure of the N-terminal domain of Als9 suggest that
these adhesins are rich in b-strand content with a significant
amount of flexible regions [17]. The isolated tandem repeat (TR)
sequences of Als5 and other Als-like adhesins, folded into b-sheet
rich structures when modelled using either Rosetta or LINUS
[25]. Additionally, a 36-mer unglycosylated synthetic peptide from
this region as well as highly glycosylated truncated mutant of Als5
containing the TR region appeared to have predominantly b-sheet
rich architectures [25].
It is noteworthy, that the Als5-SS has a strikingly different
conformation from that of Als5. Analysis for its secondary
structure content using CONTIN revealed that Als5-SS, was
predominantly a-helical (the closest matching solution suggested
73.6% a-helices and 26.4% disordered regions while the average
of all matching solutions estimated 60.2% a-helices, 16.3% b
strands, and 23.5% disordered regions) (Table S2).
Als5 has a Greater Tendency for Aggregation than Als5-
SS
The higher b-sheet content of Als5 should also be reflected in a
greater tendency for aggregation by the protein as compared to
Als5-SS. In order to test this hypothesis, we incubated the protein
at 37
oC for 2 weeks and obtained TEM images for the proteins. As
can be seen from Figure 5, GST-Als5 shows significantly higher
amount of aggregation as compared to either GST-Als5-SS or
GST alone. The aggregation of GST-Als5 that we observed is well
in keeping with the study by Ramsook et al. who showed that Als5
tended to form amyloids and precipitate out of the solution into
the medium, when expressed in S. cerevisiae [13].
Why does the Als5-SS not aggregate? The amyloidogenic region
that was previously identified in the Als5 sequence [12] also exists
in Als5-SS. Additionally, prediction by TANGO [26–28] suggests
that the C-terminal half of the SS also has a very high propensity
for beta-aggregation (Figure 6A). TEM studies confirm the
potential of the SS peptide to form aggregates (Figure 6B). Had
the amyloidogenic and SS sequences been exposed to solvent, this
should have resulted in a high tendency for aggregation in Als5-
SS. We tested this hypothesis by simultaneously incubating GST-
Als5 and the SS peptide at 37
oC for 2 days. We observed that SS
peptide as well as the GST-Als5 sample containing the SS peptide
showed significant amount of aggregation (Figure 6B). Clearly, the
Als5-SS does not have its amyloidogenic regions exposed for beta
aggregation and thus has a conformation that differs from that of
Als5.
We looked for clues from the available crystal structure to
explain how Als5-SS could differ in conformation from Als5
despite differing in only 20 residues at the C-terminus. One
probable hypothesis is that the C-terminal SS is able to fold back
and fit either into the peptide-binding pocket of the protein or
dock over the N1 domain as has been reported for the N-terminal
domains of both Als9 and Als1 [17]. If the SS in Als5-SS folds back
to interact with the N-terminal half of the protein, it is possible that
it would also introduce torsion into the protein chain, keeping it
perhaps in a more structured conformation and forcing the C-
terminal domain into a predominantly a-helical arrangement.
This could also perhaps lead to shielding/burial of the
amyloidogenic region (residues 325–329; Figure S6) of the protein.
The cleavage of the SS peptide would result in release of this
torsional constraint, exposing its amyloidogenic region, while
simultaneously allowing the C-terminal domain of the protein to
adopt a more relaxed conformation.
We hypothesised that the SS might fold back and interact with
the N1 domain (nomenclature as per [17]) rather than the peptide
binding pocket of Als5-SS because the ligand binding pocket of
Als5-SS binds peptide ligands and is therefore not likely to be
occupied by the SS (from homology modelling, the peptide
binding pocket in an energy minimised model of N-terminal
domain of Als5 does not appear to be capable of accommodating
more than one peptide; Figure S7A). To test this hypothesis, we
performed homology modelling of the N-terminal domain of Als5
Figure 5. Transmission electron microscope images showing
aggregation by GST-Als5. The proteins, GST, GST-Als5 and GST-Als5-
SS (0.4 mM of each) were incubated at 37
oC for 2 weeks before being
examined under a transmission electron microscope. As can be clearly
seen, GST-Als5, but not GST showed significant amount of aggregation,
typical of b-sheet rich proteins. GST-Als5-SS, on the other hand, showed
very poor aggregation under similar conditions. The scale bar in each
panel represents 100 nm. Left panel: 10,000X magnification. Right
panel: 25,000X magnification.
doi:10.1371/journal.pone.0035305.g005
Als5 from C. albicans
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e35305(Als5Nt) along with the SS peptide as described in Methods. The
energy minimised model of Als5Nt is shown in Figure 7A. We
observed that the C-terminal half of the SS peptide can readily
replace the C-terminal end which forms an extended strand (bG29)
over domain N1 in the Als9 structure both in the presence
(Figure 7B) or absence (Figure S7B and S7C) of the peptide ligand
(EHAHTPR).
While we are limited by the availability of structural data for the
full-length protein or even the C-terminal domain of this protein,
such a mechanism would best explain our experimental results.
Specificity of Ligand-binding of the Two Proteins is also
Different
In order to assess whether the ligand binding pockets of the two
proteins could be correlated to the differences that we observed in
their global conformation and in the differences in their adhesion
to collagen type IV, we set out to map the interaction of the two
proteins with a set of specific peptide ligands that have been
previously shown to be ligands for Als5 amplified from a human-
isolated CA1 strain of C. albicans and heterologously expressed on
the cell surface of S. cerevisiae [29].
We generated four peptides, KLRIPSV, AYKSLMT,
EHAHTPR and VSPIRLK. The first two peptides were chosen
because they had been shown to be specific for Als5 and the third
because it was reported to be incapable of binding to Als5 [29].
We chose, additionally, to make a fourth peptide with the reverse
sequence of KLRIPSV in order to determine specificity of the
interaction.
We observed that the intrinsic tryptophan fluorescence of the
protein was sensitive to peptide binding and could be used as a
reporter for the interaction. Als5 and Als5-SS have 13 and 14
tryptophan residues, respectively, of which 13 are present in the N-
terminal half of the proteins where the ligand is expected to bind.
The crystal structure of N-terminal domain of Als9 bound to
peptide also suggests a role for a conserved tryptophan in the
ligand binding [17].
The change in fluorescence emission intensity upon titration
with the peptide ligands was monitored (see Figures S8A, S8C,
S8E, S8G and Figures S9A, S9C, S9E, S9G, respectively) and the
binding plots obtained (Figures S8B, S8D, S8F, S8H and Figures
S9B, S9D, S9F, S9H, respectively) were used to calculate
dissociation constants (Kd) for the interaction (Table 1).
We discovered that neither of the proteins bound any of the
peptides at 4
oC. However, at 15
oC, GST-Als5-SS bound
EHAHTPR with Kd approximately 65 nM but did not interact
with either KLRIPSV or AYKSLMT at this temperature. GST-
Als5, on the other hand showed no binding with any of the
peptides under similar conditions. At 27
oC, GST-Als5-SS bound
to all three peptides with roughly comparable affinities. Under
these conditions GST-Als5 did not bind any of the peptides. At
37
oC, 47
oC and 52
oC both proteins showed significant amount of
binding to all the three peptides.
The scrambled peptide VSPIRLK, on the other hand, showed
no affinity for either of the protein variants at 27
oC and 47
oC,
suggesting that the interaction of the proteins with the other three
peptides was specific.
Notably, while GST-Als5-SS binds to the peptides at lower
temperatures, GST-Als5, with the GPI anchor attachment signal
removed, begins to recognize these peptides at higher tempera-
tures only, clearly indicating that the functionalities, and therefore
conformations, of the two protein variants are different. That both
proteins bind EHAHTPR, a peptide previously reported to not
bind Als5 [29], suggests that strain-specific variations or allelic
Figure 6. b-aggregation is exhibited by SS both in the absence and presence of GST-Als5. (A) Prediction of b-aggregation potential for the
GPI anchor attachment signal sequence (SS). The prediction of b-aggregation potential for the SS was done using TANGO (residues 1328–1347). Also
shown is the propensity for a-helix, b-turn and b-sheet formation in the unfolded polypeptide chain as predicted by TANGO. As can be seen from the
figure, the C-terminal half of the SS has a high propensity for b-aggregation. (B). Transmission electron microscope images showing aggregation by
SS and SS in the presence of GST-Als5. The samples, SS (40.0 mM), GST-Als5 (0.4 mM) and GST-Als5 (0.4 mM) + SS (40.0 mM) were incubated as 37
oC for
two days before TEM images were recorded. As can be seen from the figure, the SS alone is capable of aggregation. GST-Als5 aggregates both in the
absence as well as in the presence of SS. In contrast, in Figure 5 we showed that even after two weeks of incubation GST-Als5-SS showed no
propensity for aggregation, clearly indicating that the conformation adopted by the two Als5 variants is different.
doi:10.1371/journal.pone.0035305.g006
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Als5 proteins expressed on the cell surface of Candida albicans. Such
strain-specific and allelic variability in Als proteins is well
documented [30].
We concluded from these studies that the two proteins had some
differences in the ligand-binding pocket that manifested in
differences in peptide-recognition by the proteins. It is possible
that the interaction of the SS with the N-terminal domain of the
protein in Als5-SS, as suggested in the above model, perturbs the
ligand binding pocket of the protein and manifests in these
differences in ligand binding that we observe.
The high affinity of the interaction of Als5 for its peptide ligands
is also interesting to note in the biological context. Adhesion of the
pathogen to host surfaces could be dictated by very low
concentrations of appropriate ligands on the cell surface. Similar
high affinity interactions between adhesins and their ligands have
been previously reported. Recently Salgado et al. estimated that
the isolated N-terminal domain of Als1 bound to its peptide
ligands with affinities better than 10 mM [17] and Donohue et al.
showed by SPR studies that the affinity of the N-terminal domain
of Als1 for fibronectin and laminin was in the low micromolar
range [21].
Using the binding data, we also obtained van’t Hoff plots for the
interaction of the two proteins with the peptides (Figure 8A and
Figure 8B, respectively) and calculated thermodynamic parame-
ters for the interaction (Table 1).
As can be seen from Table 1, the interactions of the two proteins
with the peptides are largely endothermic processes. Further, the
binding affinity of the peptides to the proteins improves with
temperature, suggesting that the interactions are predominantly
Figure 7. Cartoon representation of Rosetta models for Als5Nt complexes. (A) Low energy Rosetta model of Als5Nt. (B) Low energy Rosetta
docked model of Als5Nt bound to peptide ligand (EHAHTPR) as well as to the eleven-residue long C-terminal peptide (KFISVALFFFL) from SS. The
Als5Nt is colored in red, the peptide ligand is shown in green and the SS peptide is shown in blue. The figures were generated using the program
PyMOL.
doi:10.1371/journal.pone.0035305.g007
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considerations. This is also supported by the increasingly negative
values of free energies for the interaction with increasing
temperature. Recent crystal structure information on the peptide
binding pocket of Als9 also supports this inference; a set of
hydrophobic residues in the binding pocket appear to make
extensive contacts with the bound peptide [17].
Discussion
In order to understand the effect of an uncleaved GPI anchor
attachment signal sequence on the conformation and function of a
protein to be GPI-anchored, we chose to study the Als5 protein of
Candida albicans.
The first requirement of this study was to be able to show that
the Als5 protein expressed and purified from the bacterial cells was
indeed ‘functional’.
In vitro studies on the conformation and function of Als proteins
have been challenging, not least due to the size of these proteins.
To date, no detailed in vitro characterization of a full-length
adhesin has been reported. But clues on the function and
properties of Als5 can be inferred from other available studies.
Studies using heterologously expressed Als5 on the cell surface of
S. cerevisiae showed that Als5 could induce adherence of the host
cells to collagen type IV, fibronectin and other extracellular matrix
proteins as well as to epithelial and endothelial cells [9] and the
process was primarily dictated by hydrophobicity [31]. Further,
yeast cells expressing Als5 could cause co-adhesion with bacterial
cells [32].
Our current set of studies, using purified GST-Als5, demon-
strated that the recombinant full-length protein is capable of
mediating adhesion. The protein adhered to collagen type IV, a
protein of the basal lamina. Additionally, we show that
carbohydrates on collagen type IV also participate in the adhesion,
although, they do not appear to be the sole determinants of the
interaction.
Our studies also indicated that the adhesion mediated by Als5 is
predominantly driven by entropic considerations and therefore is
determined primarily by hydrophobic interactions. This too is well
in keeping with available literature [31] and with the recent report
on the crystal structure of the N-terminal domain of Als9, another
C. albicans adhesin, which showed a set of hydrophobic amino
acids participating in ligand binding [17].
Since this protein is expressed in E. coli and is therefore not
glycosylated, it would seem that glycosylation of Als5 per se may not
be an essential condition for adhesion mediated by this protein.
This may not be surprising, given that the adhesion is expected to
be mediated by the N-terminal domain which is predicted to be
poorly glycosylated [4]. It remains to be seen, however, whether a
glycosylated variant of this protein would show better adhesion
in vitro as compared to this non-glycosylated form.
Previous reports with shorter fragments of Als5, deletion
constructs containing only the conserved immunoglobulin and
Thr-rich domains (Ig-T) as well as the one which additionally
possessed six tandem repeat domains (Ig-T-TR6), suggested that
the functional domains of Als5 were predominantly b-sheet-rich
[11]. In a recent paper, Ramsook et al. [13] showed that soluble
GPI-less Als5 when expressed in yeast tended to rapidly form
precipitates with amyloid characteristics, a feature typical of b-
sheet aggregation. Thus, the functional Als5 is expected to be b-
sheet-rich and aggregation-prone.
Our results regarding the secondary structure and aggregation
status of Als5 are well in keeping with available literature and
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protein.
Next, we looked to understand how the conformation and
function of Als5-SS, carrying the C-terminal signal sequence for
GPI anchor attachment, compared with that of Als5. We found
that in contrast to Als5, Als5-SS was predominantly a-helical in
nature and exhibited a much lower tendency to form aggregates.
The presence of the SS at the C-terminus also attenuates the
affinity of the peptide binding pocket of Als5 for its specific peptide
ligands, indicating that not only is the global conformation altered,
but the local conformation of the peptide-binding pocket, located
at the N-terminal half, is also perturbed. Additionally, it adheres
lesser to collagen type IV in comparison to Als5. The reduced self-
aggregation as well as adherence to collagen type IV reflects the
conformational difference of this precursor form of the protein
from that of the mature Als5. How does the short C-terminal
signal sequence impart such a large conformational difference
between Als5-SS and Als5? We favour a model wherein the SS
folds back to interact with the N-terminal domain of the protein in
Als5-SS and in doing so compels the C-terminal domain of the
protein to also adopt a more structured conformation. The
removal of the SS lifts the torsional constraint imposed upon the
C-terminal domain, allowing it to assume a more relaxed,
disordered conformation in Als5.
As mentioned earlier, proteins meant to be GPI-anchored, are
completely translocated into the ER lumen with the C-terminal
signal sequence intact [3]. This is subsequently and rapidly acted
upon by the GPI-transamidase complex, resulting in cleavage of
the SS and its replacement by a pre-formed GPI anchor precursor.
Thus, for a brief while, before the GPI-transamidase complex acts,
the precursor form of the GPI-anchored protein is present in the
lumen of the ER and capable of interacting with other proteins in
its vicinity under normal conditions.
However, under a number of conditions, the concentration of
this transient species can build up in the ER. For instance, any
aberrations in the GPI anchor biosynthetic pathway can reduce
the levels of pre-formed GPI anchor available and result in
reduced GPI anchoring of proteins. Paroxysmal nocturnal
hemoglobinuria (PNH) and inherited GPI deficiency (IGD) are
two examples of problems associated with mutations in crucial
steps of the GPI biosynthetic pathway in humans [33]. Mutations
in the C-terminal signal sequence of a protein to be GPI anchored
can also result in its reduced GPI anchoring. When working with
over-expression systems involving GPI anchored proteins too, the
possibility of these precursor proteins accumulating within the ER
lumen is real.
How does the cell deal with the precursor proteins in such
conditions? The mechanisms employed are likely to be different
depending on the cell type as well as the nature of the protein. It
has been shown, for example, in neutrophils of PNH patients that
precursor GPI-anchored proteins accumulate in the Golgi [34]. In
GPI-deficient LM-TK-mouse fibroblast cells, the precursor form
of placental alkaline phosphatase is transported out, rapidly
inactivated, and degraded by the lysosomal compartment [35].
With proteins like Als5, which have a high propensity to form
aggregates, minimizing unwanted interactions in the crowded
environment of the ER lumen, would be quite a challenge even
under normal conditions. This problem would be more acute
under abnormal GPI anchoring conditions. Our results suggest
that the precursor form of Als5 is likely to be folded into a
predominantly a-helical protein before removal of the signal
sequence. The cleavage of the C-terminal SS converts it to the
mature b-strand-rich form of the protein. Thus, it would appear
that the C-terminal signal sequence not only directs the
attachment of the GPI anchor but also holds the protein in an
a-helical conformation that is less likely to be aggregation-prone in
the absence of the SS removal. It is possible that similar strategies
are employed in the case of precursor forms of other GPI-
anchored enzymes and proteins, including adhesins, in order to
‘‘control’’ the function of these proteins during their transit
through the ER.
Supporting Information
Figure S1 Cloning of ALS5 and ALS5-SS regions in
pGEX-6-P2 vector. (A) Cloning of ALS5 region in pGEX-6P-
2 vector. ALS5 sequence was amplified by PCR (Table S1) and the
amplicon was digested with BamHI and XhoI restriction enzymes.
The restriction enzyme digested amplicon was ligated into
similarly digested pGEX-6-P2 vector and the construct after
ligation was confirmed by restriction enzyme digestion. Lane 1:
Uncut plasmid after ligation of ALS5 gene in pGEX-6P-2 vector,
Lane M: DNA molecular size marker, Lane 2: pGEX-6P-2 vector
with ALS5 region cloned and restricted with BamHI and XhoI
enzymes, resulting in release of ALS5 insert of approximately
4.0 kb in size (3984 bp) from pGEX-6P-2 vector (4.9 kb). (B)
Cloning of ALS5-SS in pGEX-6P-2 vector. ALS5-SS sequence was
amplified by PCR (Table S1) and the amplicon was digested with
BamHI and XhoI restriction enzymes. The restriction enzyme
digested amplicon was ligated into similarly digested pGEX-6-P2
vector and the construct after ligation was confirmed by restriction
enzyme digestion. Lane 1: Uncut plasmid after ligation of ALS5-SS
Figure 8. van’t Hoff plots of peptide-binding by the proteins. (A) Binding of GST- Als5 with different peptides. (B) Binding of GST-Als5-SS with
different peptides. Ka refers to the association constants for the protein-peptide interactions.
doi:10.1371/journal.pone.0035305.g008
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2: pGEX6P-2 vector with ALS5-SS sequence cloned and restricted
with BamHI and XhoI enzymes, resulting in release of ALS5-SS
insert of approximately 4.0 kb in size (4044 bp) from pGEX-6P-2
vector (4.9 kb).
(TIF)
Figure S2 MALDI-TOF analysis of GST-Als5-SS. Purified
GST-Als5-SS was run on a 6% SDS polyacrylamide gel and
stained using Coomassie Brilliant Blue R250. The band
corresponding to the purified GST-Als5-SS protein was cut from
the gel, trypsinized and taken for MALDI-TOF analysis. The
matrix used was a-cyano-4-hydroxycinnamic acid. The data was
analyzed using MASCOT software. The matched sequences
within the Als5 sequence are shown in red and the gray bars
indicate the various peptides that aligned with the sequence.
(TIF)
Figure S3 ESI-MS analysis for GST-Als5-SS. Purified
GST-Als5-SS was run on a 6% SDS polyacrylamide gel and
stained using Coomassie Brilliant Blue R250. The band
corresponding to the purified GST-Als5-SS protein was cut from
the gel, trypsinized and taken for ESI-MS analysis. The matched
peptides within the Als5 sequence are shown in red in the lower
panel.
(TIF)
Figure S4 Intact mass of GST-Als5-SS using MALDI-
TOF. The purified GST-Als5-SS protein was analyzed using
MALDI-TOF to determine the intact mass of the protein. A peak
of 168.6 kDa, corresponding to the mass of GST-Als5-SS, was
detected in the sample eluted from the glutathione-agarose
column.
(TIF)
Figure S5 Treatment of collagen type IV with N-
Glycosidase F results in decrease in adherence of GST-
Als5. A flow diagram to describe the different steps and the
various controls used in the assay. Collagen type IV (100 ml;
1 mg/ml) was immobilised overnight at 4uC in 96-well ELISA
plate. The wells were then rinsed 5 times with PBS and
incubated with N-glycosidase F (Roche) for 2 hours at 37
oCi n
50 mM sodium phosphate buffer (pH 8.0) containing 25 mM
EDTA and 1% v/v b-mercaptoethanol. After washing 5 times
with PBS, the subsequent steps were carried out as described in
Experimental Procedures. GST-Als5 was incubated before the
adherence was detected by using primary anti-GST antibody
and anti-rabbit HRP-conjugated secondary antibody and is
represented in this figure by the Absorbance at 650nm observed
upon oxidation of the specific substrate of HRP. No Glycosidase:
Only the incubation buffer of the enzyme was added. With
glycosidase: 0.5 U glycosidase was added. All other wells were
incubated at 37
oC in incubation buffer. GST control: GST was
added in place of GST-Als5; Buffer control: No immobilized
collagen; Without primary Ab: The step where primary Ab was
to be added was replaced with incubation with the buffer only.
Nearly 25% drop in adherence of GST-Als5 to collagen type IV
was observed after treatment of immobilised collagen with N-
glycosidase F.
(TIF)
Figure S6 TANGO prediction of propensity for second-
ary structure formation and b-aggregation in the
unfolded sequence of Als5. The sequence of Als5 minus the
17 residue N-terminal signal sequence and the GPI anchor
attachment signal sequence was used for the analysis. Residues
325–329 in the N-terminal domain of Als5 show a very high
propensity for b-sheet aggregation. No propensity for a-aggrega-
tion was predicted by this program for the Als5 sequence.
(TIF)
Figure S7 Homology modelling of Als5Nt-peptide com-
plexes. (A) Low energy Rosetta docked model of Als5Nt bound
to peptide ligand (EHAHTPR) colored green. (B) A cluster of top
150 ensembles shown here were chosen on the basis of all atom
Rosetta score with an intramodel Ca r.m.s.d of less than 1
Angstrom. (C) Low energy Rosetta docked model of Als5Nt
bound to the C-terminal peptide (KFISVALFFFL) from SS. The
Als5Nt is colored in red, and the C-terminal peptide of SS is
colored blue.
(TIF)
Figure S8 Binding of GST-Als5 with different peptides.
A, C, E and G show representative fluorescence spectra obtained
upon binding of GST-Als5 with the peptide EHAHTPR at 15
oC,
27
oC, 37
oCa n d4 7
oC, respectively. B, D, F and H represent the
binding plots of GST-Als5 with different peptides at 15
oC, 27
oC,
37
oCa n d4 7
oC, respectively. Each data point gives the average of
three independent measurements done in duplicates and the
error bars denote standard deviations. Spectra 1–7 represent
binding of peptides with GST-Als5 in the following order of
increasing concentrations of the peptides: 1: no peptide; 2:
0.037 mM; 3: 0.074 mM; 4: 0.443 mM; 5: 0.804 mM; 6:
1.154 mM; 7: 1.5 mM.
(TIF)
Figure S9 Binding of GST-Als5-SS with different pep-
tides. A, C, E and G panels show representative fluorescence
spectra obtained upon binding of GST-Als5-SS with the peptide
EHAHTPR at 15
oC, 27
oC, 37
oC and 47
oC, respectively. B, D, F
and H represent the binding plots of GST-Als5-SS with different
peptides at 15
oC, 27
oC, 37
oC and 47
oC, respectively. Each data
point give the average of three independent measurements done in
duplicates and the error bars denote standard deviations. Spectra
1–7 represent binding of peptides with GST-Als5-SS in the
following order of increasing concentrations of the peptides: 1: no
peptide; 2: 0.037 mM; 3: 0.074 mM; 4: 0.443 mM; 5: 0.804 mM; 6:
1.154 mM; 7: 1.5 mM.
(TIF)
Table S1 Primer sequences used for cloning of ALS5
and ALS5-SS region into pGEX-6P-2 vector. The primers
ALS5 FP and ALS5 RP were used to amplify ALS5 gene from the
genomic DNA of C.albicans strain CAI4. The primers ALS5-SS FP
and ALS5-SS RP were used to amplify ALS5-SS sequence from the
genomic DNA of C.albicans strain CAI4. The BamHI and XhoI
restriction enzyme sites in the primer sequences, used for cloning,
are shown in italics.
(DOCX)
Table S2 Secondary structure predictions for the Als5
and Als5-SS proteins using CONTIN software (DICHRO-
WEB: http://dichroweb.cryst.bbk.ac.uk). The secondary structure
content was predicted after subtraction of the GST spectrum from
that of the respective fusion proteins.
(DOCX)
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